Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

New Horizon Health Ltd

6YZ
Current price
1.62 EUR 0 EUR (0.00%)
Last closed 14.14 HKD
ISIN KYG6485S1021
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 6 350 909 163 HKD
Yield for 12 month -27.04 %
1Y
3Y
5Y
10Y
15Y
6YZ
21.11.2021 - 28.11.2021

New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People's Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The company is also involved in the research and development of medical diagnostic technology; provision of technical services, transfers, and consultation; and medical services, as well as financing services; manufacturing and sales of medical and laboratory equipment, and fecal occult blood test kits; and technological import and export activities. The company was founded in 2015 and is headquartered in Hangzhou, China. Address: T1 Building, Hangzhou, China, 310052

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

359.21 HKD

P/E ratio

58.9167

Dividend Yield

Current Year

+834 624 239 HKD

Last Year

+232 136 958 HKD

Current Quarter

+897 595 288 HKD

Last Quarter

Current Year

+705 016 135 HKD

Last Year

+168 728 387 HKD

Current Quarter

+815 575 258 HKD

Last Quarter

Key Figures 6YZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -101 155 141 HKD
Operating Margin TTM -6.54 %
PE Ratio 58.9167
Return On Assets TTM -2.47 %
PEG Ratio
Return On Equity TTM 4.36 %
Wall Street Target Price 359.21 HKD
Revenue TTM 1 363 278 699 HKD
Book Value 6.3 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 264.6 %
Dividend Yield
Gross Profit TTM 646 784 734 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin 8.2 %

Dividend Analytics 6YZ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 6YZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 6YZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 58.9167
Forward PE
Enterprise Value Revenue 3.682
Price Sales TTM 4.6586
Enterprise Value EBITDA 706.5108
Price Book MRQ 1.9617

Financials 6YZ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 6YZ

For 52 weeks

13.77 HKD 26.33 HKD
50 Day MA 14.15 HKD
Shares Short Prior Month
200 Day MA 18.24 HKD
Short Ratio
Shares Short
Short Percent